Parity is associated with an expanded macrophage population in the mammary gland

International Journal of Oncology

Volumn 37, Issue 5, 2010, Pages 1195-1202

  Zhao, Wei ^a   Grubbs, Clinton J ^b   Myers, Ronald K ^a   Nilsen Hamilton, Marit ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Macrophage; Mammary gland; Parity

Indexed keywords

MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BREAST CANCER; BREAST EPITHELIUM; CANCER INCIDENCE; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; MACROPHAGE; MAMMARY GLAND; NEUTROPHIL; NONHUMAN; PARITY; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TUMOR GROWTH;

EID: 77957866725     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000771     Document Type: Article

References (52)

1. Newcomb PA, Storer BE, Longnecker MP, et al: Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 330: 81-87, 1994.
2. Russo J and Russo IH: Influence of differentiation and cell kinetics on the susceptibility of the rat mammary gland to carcinogenesis. Cancer Res 40: 2677-2687, 1980. (Pubitemid 10049312)
3. Clavel-Chapelon F: Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer 86: 723-727, 2002.
4. Collaborative Group on Hormonal Factors in Breast Cancer, Breast Cancer and Breast Feeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet 360: 187-195, 2002.
5. Colditz GA and Rosner BA: What can be learnt from models of incidence rates? Breast Cancer Res 8: 208, 2006.
6. Albrektsen G, Heuch I, Thoresen S and Kvale G: Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol Biomarkers Prev 15: 65-69, 2006.
7. Manjer J, Balldin G, Zackrisson S and Garne JP: Parity in relation to risk of axillary lymph node involvement in women with breast cancer. Results from Swedish population-based series of 3,472 consecutive cases. Eur Surg Res 37: 179-184, 2005.
8. Largent JA, Ziogas A and Anton-Culver H: Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer. Breast Cancer Res 7: R541-R554, 2005.
9. Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA and Marchbanks PA: Reproductive history and mortality after breast cancer diagnosis. Obstet Gynecol 104: 146-154, 2004. (Pubitemid 40458918)
10. Russo J and Russo IH: Differentiation and breast cancer. Medicina (B Aires) 57 (Suppl. 2): S81-S91, 1997.
11. O'Malley CJ, McColl BK, Kong AM, Ellis SL, Wijayaratnam AP, Sambrook J and Mitchell CA: Mammalian inositol polyphosphate 5-phosphatase II can compensate for the absence of all three yeast Sac1-like-domain-containing 5-phosphatases. Biochem J 355: 805-817, 2001. (Pubitemid 32434100)
12. D'Cruz CM, Moody SE, Master SR, et al: Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 16: 2034-2051, 2002.
13. Uehara N, Unami A, Kiyozuka Y, Shikata N, Oishi Y and Tsubura A: Parous mammary glands exhibit distinct alterations in gene expression and proliferation responsiveness to carcinogenic stimuli in Lewis rats. Oncol Rep 15: 903-911, 2006.
14. Sica A, Larghi P, Mancino A, et al: Macrophage polarization in tumour progression. Semin Cancer Biol 18: 349-355, 2008.
15. Ryon J, Bendickson L and Nilsen-Hamilton M: High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 367: 271-277, 2002. (Pubitemid 35176915)
16. Fassett JT, Hamilton RT and Nilsen-Hamilton M: Mrp4, a new mitogen-regulated protein/proliferin gene; unique in this gene family for its expression in the adult mouse tail and ear. Endocrinology 141: 1863-1871, 2000.
17. Bradley PP, Priebat DA, Christensen RD and Rothstein G: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209, 1982.
18. Robyt JF and White BJ: Biochemical Techniques Theory and Practice. Brooks/Cole Publishing Company, Monterey, CA, USA, 1987.
19. Stein T, Salomonis N and Gusterson B: Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia 12: 25-35, 2007. (Pubitemid 46394923)
20. Atabai K, Sheppard D and Werb Z: Roles of the innate immune system in mammary gland remodeling during involution. J Mammary Gland Biol Neoplasia 12: 37-45, 2007. (Pubitemid 46394924)
21. Clarkson RWE, Boland MP, Kritikou EA, Lee JM, Freeman TC, Tiffen PG and Watson CJ: The genes induced by signal transducer and activators of transcription (STAT)3 and STAT5 in mammary epithelial cells define the roles of these STATs in mammary development. Mol Endocrinol 20: 675-685, 2006.
22. Clarkson RW, Wayland MT, Lee J, Freeman T and Watson CJ: Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 6: R92-R109, 2004.
23. Gough MJ, Ruby CE, Redmond WL, Dhungel B, Brown A and Weinberg AD: OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. Cancer Res 68: 5206-5215, 2008.
24. Ohshima Y, Yang LP, Uchiyama T, et al: OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 92: 3338-3345, 1998.
25. Stein T, Morris J, Davies C, et al: Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 6: R75-R91, 2004.
26. Monks J, Geske FJ, Lehman L and Fadok VA: Do inflammatory cells participate in mammary gland involution? J Mammary Gland Biol Neoplasia 7: 163-176, 2002.
27. Schneider T and Issekutz AC: Quantitation of eosinophil and neutrophil infiltration into rat lung by specific assays for eosinophil peroxidase and myeloperoxidase. Application in a Brown Norway rat model of allergic pulmonary inflammation. J Immunol Methods 198: 1-14, 1996. (Pubitemid 26348913)
28. Richards RC and Benson GK: Ultrastructural changes accompanying involution of the mammary gland in the albino rat. J Endocrinol 51: 127-135, 1971.
29. Mayberry HE: Macrophages in post-secretory mammary involution in mice. Anat Rec 149: 99-111, 1964.
30. Atabai K, Fernandez R, Huang X, et al: Mfge8 is critical for mammary gland remodeling during involution. Mol Biol Cell 16: 5528-5537, 2005.
31. Lund LR, Romer J, Thomasset N, et al: Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122: 181-193, 1996.
32. Schedin P, O'Brien J, Rudolph M, Stein T and Borges V: Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia 12: 71-82, 2007. (Pubitemid 46394927)
33. Medina D and Kittrell FS: p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res 63: 6140-6143, 2003. (Pubitemid 37255152)
34. Sivaraman L, Conneely OM, Medina D and O'Malley BW: p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci USA 98: 12379-12384, 2001. (Pubitemid 33019954)
35. Ingman WV, Wyckoff J, Gouon-Evans V, Condeelis J and Pollard JW: Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn 235: 3222-3229, 2006. (Pubitemid 44888188)
36. Gouon-Evans V, Rothenberg ME and Pollard JW: Postnatal mammary gland development requires macrophages and eosinophils. Development 127: 2269-2282, 2000. (Pubitemid 30386567)
37. Nilsen-Hamilton M, Liu Q, Ryon J, Bendickson L, Lepont P and Chang Q: Tissue involution and the acute phase response. Ann NY Acad Sci 995: 94-108, 2003. (Pubitemid 36706617)
38. Devireddy LR, Teodoro JG, Richard FA and Green MR: Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation. Science 293: 829-834, 2001.
39. Gierach GL, Modugno F and Ness RB: Relations of gestational length and timing and type of incomplete pregnancy to ovarian cancer risk. Am J Epidemiol 161: 452-461, 2005. (Pubitemid 40315616)
40. Hanna L and Adams M: Prevention of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 20: 339-362, 2006.
41. Lambe M, Wuu J, Weiderpass E and Hsieh CC: Childbearing at older age and endometrial cancer risk (Sweden). Cancer Causes Control 10: 43-49, 1999. (Pubitemid 29134751)
42. Modugno F, Ness RB, Chen C and Weiss NS: Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 14: 2840-2847, 2005.
43. Pettersson B, Adami HO, Bergstrom R and Johansson ED: Menstruation span-a time-limited risk factor for endometrial carcinoma. Acta Obstet Gynecol Scand 65: 247-255, 1986. (Pubitemid 16057701)
44. Pike MC, Pearce CL and Wu AH: Prevention of cancers of the breast, endometrium and ovary. Oncogene 23: 6379-6391, 2004. (Pubitemid 39265506)
45. Purdie DM and Green AC: Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol 15: 341-354, 2001.
46. Berger T, Cheung CC, Elia AJ and Mak TW: Disruption of the Lcn2 gene in mice suppresses primary mammary tumor formation but does not decrease lung metastasis. Proc Natl Acad Sci USA 107: 2995-3000, 2010.
47. Leng X, Ding T, Lin H, et al: Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res 69: 8579-8584, 2009.
48. Aharinejad S, Paulus P, Sioud M, et al: Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res 64: 5378-5384, 2004.
49. Lin EY, Nguyen AV, Russell RG and Pollard JW: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193: 727-740, 2001.
50. Paulus P, Stanley ER, Schafer R, Abraham D and Aharinejad S: Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts. Cancer Res 66: 4349-4356, 2006.
51. Zhang J, Wu Y, Zhang Y, Leroith D, Bernlohr DA and Chen X: The role of lipocalin 2 in the regulation of inflammation in adipocytes and macrophages. Mol Endocrinol 22: 1416-1426, 2008. (Pubitemid 351787001)
52. O'Brien J and Schedin P: Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer? J Mammary Gland Biol Neoplasia 14: 145-157, 2009.